One of the biggest challenges biotechnology and biotherapeutic companies face is in the development of manufacturing processes that deliver safe, cost-effective, and efficient products.
Other content in this Stream
Astrea Bioseaparations Application note on Purification of monoclonal antibodies from cell culture supernatant containing Pluronic® F-68 using MAbsorbent® A2P HF
Astrea Bioseparations technical note on a Chromatography Adsorbent for Effective Removal of Endotoxins from Biopharmaceuticals
In 2018 Astrea Bioseparations created a special report in collaboration with BioProcess International which explains their new tool for rapid development of downstream processes.